Today's jam-packed edition includes breaking news on a most-favored-nation drug policy and reconciliation legislation; also tariffs and an FDA-approved CRISPR pig. (843 words, 4 minutes, 12 seconds) ...

Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...

"BIO is a crucial trade group representing all biotech and biopharma companies with influence on policies affecting our business and patients with rare diseases in the U.S. Through our participation ...

BIO is in search of dynamic, professional candidates possessing the expertise and education outlined in the job titles listed below. If you are interested in working at BIO, please visit our current ...

Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...

Apply today to join an unparelled network of BIO Members and to benefit from a number of resources and event discounts. BIO membership is available only to bona fide organizations that promote ...

Thank you for being a member of BIO. Join the conversation and let everyone know you're a member using the resources below!

BIO launches a new campaign to explain why we vaccinate – and why it's good for America. We have details, plus how drug companies are investing in U.S. manufacturing, news on drug prices and IP, and ...

Today, we take a deep dive into what’s been happening in the state legislatures—here’s what BIO’s watching related to healthcare and agriculture. Plus, two bills designed to strengthen U.S. patents ...